Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ewelina Trela
Therapy of Chronic Myeloid Leukemia: Twilight of the Imatinib Era?
ISRN Oncology
Related publications
Dasatinib in the Treatment of Imatinib Refractory Chronic Myeloid Leukemia
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients
Gene Expression Signature of Primary Imatinib-Resistant Chronic Myeloid Leukemia Patients
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
The Development of Imatinib as a Therapeutic Agent for Chronic Myeloid Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Knockdown of Ribonucleotide Reductase Regulatory Subunit M2 Increases the Drug Sensitivity of Chronic Myeloid Leukemia to Imatinib‑based Therapy
Oncology Reports
Medicine
Cancer Research
Oncology
Functional Activity of Cd34-Positive Cells in Chronic Myeloid Leukemia Patients With Different Response to Imatinib Therapy
Experimental Oncology
Cancer Research
Oncology
Cost Effectiveness of Therapeutic Drug Monitoring for Imatinib Administration in Chronic Myeloid Leukemia
PLoS ONE
Multidisciplinary
Spred2 Modulates the Erythroid Differentiation Induced by Imatinib in Chronic Myeloid Leukemia Cells
PLoS ONE
Multidisciplinary
Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental